The Visual Effects Society recently held its 2024 VES Awards ceremony at the Beverly Hilton, with Disney’s The Creator and Sony’s Spider-Man: Across the Spider-Verse leading the pack with seven nominations each. The evening saw both films scoop up several awards, with Spider-Man clinching the first prize for Outstanding Created Environment in an Animated Feature,
0 Comments
Nvidia recently reported its fourth fiscal quarter earnings, exceeding all expectations on Wall Street. The company’s earnings per share came in at $5.16 adjusted, surpassing the forecasted $4.64. On the revenue front, Nvidia reported $22.10 billion, significantly higher than the expected $20.62 billion. Despite already heightened expectations for growth, Nvidia anticipates even better results for
0 Comments
In a shocking turn of events, federal prosecutors in New York have unveiled a harrowing tale of a Japanese Yakuza leader’s attempt to traffic nuclear materials from Burma to potentially be used in Iran’s nuclear weapons program. The accused gangster, Takeshi Ebisawa, and his associates went to great lengths to showcase samples of these dangerous
0 Comments
The recent plummet of Palo Alto Networks shares by 28% has sent shockwaves through the cybersecurity industry. This sharp decline followed the company’s decision to slash its full-year revenue outlook, marking it as the worst trading session since its initial public offering in 2012. Despite a remarkable doubling in stock value in 2023, the company’s
0 Comments
The American Gastroenterological Association (AGA) has recently endorsed the use of fecal microbiota-based therapies for recurrent Clostridioides difficile infections (CDIs). The guideline recommendations suggest that immunocompetent adults with recurrent CDIs should receive such therapies after completing treatment with standard-of-care antibiotics. On the other hand, mildly or moderately immunocompromised adults with recurrent CDIs are advised to
0 Comments